The company VR Life, specializing in rehabilitation in virtual reality, won the prestigious second place in the 2023 Company of the Year competition in the Moravian-Silesian region. These awards demonstrate the rapid growth and innovative approach of the company, which, with the support of the Molecular HydroGEN Investment Group, uses modern technology to improve healthcare services.

VR Life, which uses the VR Vitalis product to implement virtual reality in healthcare, received a significant investment of 15 million CZK from the Molecular HydroGEN Investment Group, part of the H2 Global Group. This investment has enabled its rapid development and creative approach, which is appreciated not only by professionals but also by customers.

“We are excited about how quickly Dr. Jana Trdá’s team is moving forward. Collaborating with them allows us to help people rehabilitate faster and more efficiently," said Martin Frais, Director of Molecular HydroGEN Investment Group. VR Life and Molecular HydroGEN Investment Group have patented the combination of virtual reality rehabilitation with the inhalation of molecular hydrogen from H2 Medical products, representing a unique fusion of the latest technological trends.

Iveta Štočková, Head of Communication and Marketing at VINCI Construction CS Group, responded to the award, saying: "It’s great to see how innovations in various industries are opening up new opportunities and contributing to the development of regions. Competitions like Company of the Year or Entrepreneur of the Year reward this effort and bring it to the attention of the public."

VR LIFE is a leading provider of rehabilitation services in virtual reality. Its award in the Company of the Year competition confirms its innovative approach and continuous efforts to improve patient care. In August this year, it joined forces with Molecular HydroGEN Investment Group, part of the H2 Global Group. The group invested 15 million CZK in the company, which uses virtual reality in healthcare through its VR Vitalis product, acquiring a 20% stake.

"This award only confirms that this investment was the best possible. We look forward to further development and innovations in the world of virtual reality in healthcare," adds Frais.